China Arthroscopy Market Growth & Trends

The China arthroscopy market size is expected to reach USD 485.9 million by 2027, registering a CAGR of 6.6% over the forecast period, according to a new report by Grand View Research, Inc. Increasing incidence of sports injuries, growing prevalence of arthritis is expected to drive the market over the next few years.

In sports, such as football, basketball, and tennis, knee injuries are most common. Running injuries can result from abrupt stops, tilting, pivoting, jumping, and sharp turns. According to the MedSci-Clinician Development Platform, sports injuries account for 10% - 20% of all injuries in China and are on the rise. The current rate of sports injuries in China is almost identical to that of some developed countries, such as the U.S.

Arthroscopy is the most effective treatment for major sports injuries. It is a minimally invasive procedure that is suggested for sports injuries in cases where open surgery is not required. Arthroscopy is commonly performed to repair knee and shoulder injuries, such as ACL tears, SLAP, and Bankart labral tears, meniscus tears, AC joint arthritis and separations, shoulder joint fractures, bursitis, and impingement, torn rotator cuffs, and cartilage damage, and ligament tears. All these factors, thereby, propel the growth of the market.

However, the sudden onset of the COVID-19 pandemic negatively impacted the market. Postponement of surgeries related to knee, shoulder, hip, and other joints resulted in declining sales of arthroscopy devices.

China Arthroscopy Market Report Highlights

  • The ablation systems product segment accounted for 45.4% of the revenue share in 2019 on account of a rising prevalence of chronic pain disorders such as osteoporosis and arthritis, and preference for minimally invasive surgeries
  • The knee application segment held the largest revenue share in the market in 2019.Increasing prevalence of knee arthritis, technological advancements, and rapid adoption of arthroscopes in joint replacement surgeries for precision are major factors likely to drive the segment
  • The arthroscope segment is expected to witness a CAGR of over 8.8% over the forecast period. Technological advancements coupled with a growing inclination for non-invasive surgical procedures is expected to propel segment growth over the projected period
  • Key players operating in the market are engaging in new product launches and mergers and acquisitions to gain revenue share and strengthen market presence. For instance, in September 2020, Smith & Nephew launched REDAPT System for revision total hip arthroplasty in China